Pramipexole Dihydrochloride
Pramipexole dihydrochloride tablets are a non-ergot dopamine agonist indicated for the treatment of: Parkinson’s disease (PD) (1.1) Moderate-to-severe primary Restless Legs…
Glenmark Pharmaceuticals Inc., USA Products: Prescription Medications Section, Page 20
Pravastatin Sodium
Therapy with lipid-altering agents should be only one component of multiple risk factor intervention in individuals at significantly increased risk for atherosclerotic vascular disease…
Propafenone Hydrochloride
Propafenone hydrochloride extended-release capsules are indicated to prolong the time to recurrence of symptomatic atrial fibrillation (AF) in patients with episodic (most likely…
Ranitidine
Ranitidine tablets USP are indicated in: 1. Short-term treatment of active duodenal ulcer. Most patients heal within 4 weeks. Studies available to date have not assessed the safety of…
Ranolazine
Ranolazine extended-release tablets are indicated for the treatment of chronic angina. Ranolazine extended-release tablets may be used with beta-blockers, nitrates, calcium channel…